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Abstract
Considerable analytical work during the COVID-19 pandemic has been devoted to developing predic-
tive models to evaluate the merits of potential governmental interventions versus the cost of not carrying
them out. These prospective modeling efforts are based on formal assumptions, like the choice of epi-
demiological mode, and on the extrapolation of past timecourse data to the future. As both these aspects
carry substantial potential for error, trusted models used by decision-makers of public policy undergo
nearly continuous revision cycles. Less methodologically developed is to assess retrospectively the effects
these interventions had. Here we present a proposal for a model-free data-driven framework. We use a
sparse regression method to fit the dynamic progression of the data (the Rt parameter) with the least
number of changes, allowing us to attribute discrete change events to specific intervention events. Since
the sparse fit yields a discrete jump between two constant Rt, we follow do-operator prescriptions and
simulate the counterfactual case by forcing Rt to stay at the pre-jump value. We then attribute a nominal
value to the intervention from the difference between true evolution and simulated counterfactual, for
example, in terms of reducing the number of cases or accelerating the timecourse towards a milestone.
As an example, we show that the recommendation to use facemasks for all activities would result in a
putative total of 71000 (95% CI 64000 to 78000) fewer official cases in New York State.
1 Introduction
To quantitatively analyze causality, we need to evaluate both branches of an intervention [1]: one in which
the intervention did happen, and one in which it did not. Nowhere is this clearer than in the need for
double-blind randomized control trials (RCT). If people are allowed to self-select for the treatment arm
over the placebo arm, the reasons behind their choice may be correlated with their prognosis; people might
self-select more the more severe their situation. Conversely, if the doctor can choose which patient to assign
to each arm, perhaps she will feel impelled by ethics to switch the patients at higher risk to the treatment
arm, leaving an unbalanced study in which the placebo patients were at a smaller risk, to begin with; the
only solution is to double-blind the study.
Although possible [2], RTCs are not the norm in public health epidemiological intervention. Even if
implemented, there is no such thing as a “placebo arm” for travel restrictions or a double-blind school
closure. Since a placebo or double-blind trials are not possible, there is an indirect causal path between the
treatment and the outcome [3, 4]. For example, people in zip codes with open schools might be more careful
with their hygiene because they know that they are at a higher risk that people in zip codes where the
schools are closed. When the second branch of the intervention did not happen, it is called a counterfactual
(“contrary to the facts”). One option to measure the direct effect of an intervention, and the one that we
use in this work, is to estimate or simulate the counterfactual branch [5, 6].
An intervention that has recently caused major controversies is the use of masks among the general
public to reduce the spread of COVID-19[7, 8, 9]. At the start of the pandemic, it was widely assumed that
the primary mode of transmission of SARS-CoV-2 was through coughing or through contact with surfaces.
Extensive shortages of personal protective equipment for health workers led to an initial recommendation
for general population not to wear masks. While there are no extant studies showing surgical masks reduce
transmission of SARS-CoV-2 in humans, there is evidence that surgical masks reduce viral shedding of other
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coronaviruses [10], and that they reduce transmission of SARS-CoV-2 in animal models [11]. There is also
evidence that cloth masks might filter SARS-CoV-2[12]. The Centers for Disease Control and Prevention
(CDC) changed its guidelines on April 3rd, 2020, and started recommended widespread use of masks [13].
According to the CDC, the rationale behind its policy change was the increase in evidence that asymptomatic
and presymptomatic people are infectious [14, 15, 16, 17, 18, 19] and that there are many undetected cases
[20]. Additionally, at the time of the recommendation change, evidence accumulated that SARS-CoV-2 was
likely transmitted in aerosols. On June 5th, the World Health Organization (WHO) changed its guidelines
and recommended governments to encourage the general public to wear masks in specific situations, like
grocery stores [21]. Also, WHO specifies: “At present, there is no direct evidence (from studies on COVID19
and in healthy people in the community) on the effectiveness of universal masking of healthy people in the
community to prevent infection with respiratory viruses, including COVID-19” [21]. Meanwhile, according
to The European Centre for Disease Prevention and Control (ECDC), there is no evidence that masks can
prevent people from being infected [22], and they furthermore suggest the use of masks may increase the risk
of infection. The reason for the WHO and ECDC statements is that there is no work on the widespread use
of masks by the general public as a non-pharmaceutical intervention (NPI). In this paper, we fill this gap
showing that the use of masks as NPI reduced the number of positive cases in the New York State (NYS).
Here, we present a framework to analyze data from the COVID-19 epidemic. In this framework, we use
the odds of a positive test as our dependent variable, rather than the number of positive tests [23] or the
number of deaths [24]. We motivate a linear equation for the evolution of this dependent variable by using
the Susceptible-Infected-Recovered (SIR) model [25, 26]. Finally, we carry out a LASSO [27] regression to
fit the data, to obtain a piecewise-linear fit to the logarithm of the odds ratio with the smallest number of
breaks. We show that this regression can find the times at which interventions are made, allowing us to
simulate alternative scenarios where these interventions did not happen and assess their net impact.
Our code is available on GitHub at https://github.com/ababino/corona.
2 Data
We collected data from the New York State Health Department available at https://health.data.ny.gov/
Health/New-York-State-Statewide-COVID-19-Testing/xdss-u53e. The dataset contains the number of
new positive tests, and the number of total tests performed each day and county in NYS. The first record of
the database is on March 2nd, 2020. The last record used was on May 15th, 2020. We only use information
since March 15th, 2020, because before that date, the testing was not widespread, and people were selected
for testing not based on symptoms. Mainly, there was a cluster of infection in Westchester County, and most
of the tests were performed based on close contacts of positive individuals. The last day that we use for our
analysis is May 15th, 2020, because, the day after, some regions of NYS started to reopen. In Fig. 1, we
show the number of new tests new positive cases each day.
3 The Framework
3.1 The odds as the dependent variable
As can be seen in Fig. 1 the number of daily positive tests, Positivet, oscillates in synchrony with the number
of tests. To overcome this source of noise, we propose to use the odds of a positive test:
Oddst =
Positivet
Negativet
where Negativet is the number of negative tests on day t.
We show the evolution of the Odds in Fig. 2. The noise due to the variation in the number of tests is
reduced, and a trend emerges.
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3.2 The evolution of the Odds
As has been shown previously [28], under the SIR model hypotheses, the number of newly infected individuals
in a given day, kt, can be approximated as:
kt = kt−1e(Rt−1−1)γ
where Rt is the instantaneous reproduction number [28], and γ
−1 is the average infectious period [26]
estimated as 7.5 days (95% CI 5.3 to 195.3) according to [20] (in agreement with [29], but higher than
reported in [30]).
Since we do not have access to the total number of infected individuals, but only to the tested population,
we have to use some statistical assumptions about this population. If we assume that the people being tested
is a random sample of the population with COVID-19-like symptoms we can state that1:
Positivet = Pt(I|symptoms)Pt(symptoms)Nft (1)
where Pt(I|symptoms) is the probability of a patient being positive for SARS-CoV-2 given that she is
symptomatic, Pt(symptoms) is the probability of having COVID-19-like symptoms, N is the total population,
and ft is the fraction of people with symptoms that are selected to be tested (this number can be different
each day, for example, if the number of tests available changes). Similarly:
Negativet = Pt(notI|symptoms)Pt(symptoms)Nft (2)
where Pt(notI|symptoms) is the probability of a patient being SARS-CoV-2 negative given he has COVID-19-
like symptoms.
Now, if we assume that Pt(symptoms|I) = cte, we can use Bayes theorem to show that:
Pt(I|symptoms)Pt(symptoms) ∝ Pt(I) = kt
N
Then:
Pt(I|symptoms)Pt(symptoms) ∝ kt (3)
Finally, if we assume that Pt(notI|symptoms)Pt(symptoms) = cte:
Oddst =
Pt(I|symptoms)Pt(symptoms)Nft
Pt(notI|symptoms)Pt(symptoms)Nft
Oddst =
Pt(I|symptoms)Pt(symptoms)
Pt(notI|symptoms)Pt(symptoms)
Oddst ∝ kt
Oddst = Oddst−1e(Rt−1−1)γ (4)
We used four sets of hypotheses. First, we use the assumptions of the SIR model. Second, we use that
the tested population is a random sample from the population with COVID-19-like symptoms (Eqs. 1 and
2). This assumption does not hold, for example, if the basis for testing someone is that she was in contact
with a confirmed case. Third, we assume that Pt(notI|symptoms)Pt(symptoms) = cte. This hypothesis is
equivalent to say that the number of people with COVID-19-like symptoms but without the SARS-CoV-2
(for example, people with the flu) is constant, or its change rate is negligible compared with the change
rate in the number of symptomatic people with SARS-CoV-2. Fourth, we use that the symptoms show
up instantaneously and that the tests are performed and processed on the same day (Eq. 3). This last
hypothesis is not true, and it is the reason why, in our analysis, the effects of the interventions show a delay
to onset between 8 and 11 days.
1The following derivation was suggested to us by Will Meierjurgen Farr on this GitHub Issue https://github.com/k-sys/
covid-19/issues/45#issuecomment-623782130
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3.3 Linearization
We write Eq. 4 as a linear function of the rate of change of Rt. Defining
bt = e
(Rt−1)γ (5)
We can write Eq. 4 as:
Oddst = bt−1 ∗Oddst−1 (6)
Now, instead of using bt as the parameters to estimate we decompose each bt as follows:
bt =
t∏
i=0
ai (7)
The ais represent the rate of change of the variable bt in logarithmic scale. Next, we replace the 7 in 6
Oddst =
t−1∏
i=1
ai ∗Oddst−1
Oddst =
t−1∏
i=1
ai ∗
t−2∏
i=1
ai ∗Oddst−2
Oddst =
t−1∏
k=1
k∏
i=1
ai ∗Odds1
Oddst =
t−1∏
i=1
at−ii ∗Odds1
Now, we linearize this result, and we generalize it to the case where t = 0 using the max function:
log(Oddst) =
max(t−1,1)∑
i=1
(t− i)log(ai) + log(Odds1) (8)
We can write 8 as a linear problem with the following definitions:
y = Xβ + β0 (9)
yt = log(Oddst) (10)
Xt,i = max(t− i, 0) (11)
Importantly, the SIR hypotheses are only necessary to draw the connection to Rt (Eq. 5). However, Eq. 8
might hold even if the SIR hypotheses do not. What would change is the interpretation of the parameters.
3.4 LASSO regression and feature selection
Since in Eq. 9, we have as many regressors as samples, and we assume that the changes in a are only due
to top-down interventions we use a LASSO regression to fit the data. This regression minimizes the loss
function:
Err =
1
n
n∑
t=1
(yt − β0 −
n−1∑
i=1
βiXt,i)
2 + α
n−1∑
i=0
|βi| (12)
This approach finds a sparse set of βi. We add two extra steps to sparsify even further this set of param-
eters. If there are contiguous βi 6= 0, we set to zero all of them but the first in the chunk. Then, we fit the
selected regressors using ordinary least squares, and we recursively remove the betai with p-values
∗ > 0.05,
where p-values∗ are the Bonferroni corrected p-values. Using the LARS algorithm [31], we repeat these steps
for different values of the hyperparameter α, and we use the fit that minimizes the Bayesian Information
Criterion [32].
4
Figure 1: Daily number of new cases and test in the NYS.
4 Results
We show the results of fitting the Eq. 9 in Fig. 2. The regression shows three discontinuities in the evolution
of the Odds. We should stress the fact that these three breaks are not an input of the user. On the contrary,
this is the result of applying the LASSO regularization.
In Figure 3, we show the Rt as a function of time, which is calculated using the regression parameters.
This plot shows the regressed Rt dropping down from 2.1 to 1.6 on March 23th and then to 0.72 on March
30th, 8 days after the closure of all nonessential business. There is a third drop from 0.72 to 0.44 on April
14th, 11 days after the CDC changed their guidelines and recommended to wear masks, and two days after
NYS enforced the use of masks for public employees.
Finally, the advantage of the sparsifying framework is that we can pair each intervention with a specific
change in the fitted curve. Then, we can simulate a counterfactual scenario by setting the corresponding
parameter to zero, and the regressed line would have continued at the preceding rate 2. Take the case of
the public wearing of masks. From our fit shown in Figure 2, we observe that on April 14th, Rt changed
from 0.72 to 0.44. We can interpret that our counterfactual to this intervention is that if the public had not
used masks, Rt would have stayed at 0.72, or in causal inference jargon do(no masks). As we show in Fig.
2 (orange line), removing the intervention would have resulted in a much more drawn-out dwindling of the
case curve.
Now, we can use the counterfactual odds to calculate the counterfactual number of positive tests. Then,
we can compare this to the actual number of positive cases. Doing this yields that wearing masks had the
effect of decreasing the number of positive cases by 71000 cases (95% CI 64000 to 78000).
5 Conclusion and Outlook
Our framework is data-driven, and the main results rely on one hypothesis: the odds follow the exponential
growth in Eq.(6). For the dataset analyzed here, this hypothesis holds (see Fig. 2). Nevertheless, this
2The changes in Rt could indeed be due to other factors such as a mutation in the virus or changes in weather. But, since
these changes are rather sudden, we argue that these alternative explanations are unlikely
5
Figure 2: The odds of a positive test in logarithmic scale. Under the assumptions of the model, this variable
should be piece-wise linear. The dots are the data points. The blue line is the LASSO fit and the blue
shade are is the 95% CI. The orange line is the counterfactual odds of the scenario where masks were not
recommended; in causal inference jargon, do(not masks); and the orange shaded area is its 95% CI.
may not be true for other datasets where the tested population is not selected based on symptoms but
on a different criterion (such as having been in contact with a positive case). As regions enter a phase of
reopening, with more testing capabilities and biased to certain activities, it will be necessary to add that
information to the databases to apply this framework.
The calculation of Rt does rely on more hypotheses: that the serial interval is 7.5 days, that the SIR
model describes the infectious process well, and that the number of susceptible individuals can be considered
constant during each day. Nevertheless, none of these assumptions would change the fact that Rt > 1 or
Rt < 1. As well as [23], we believe that the growth rate is a better measurement to assess the state of an
epidemic, which is the value of the slope of the log(odds) plot, as in Fig. 2 (if Eq. 6 holds). This value
carries the same information as the Rt but relies on less hypothesis.
As we already mentioned, a problem with Eq. 3 is that it assumes that there is no delay between infection
onset and the test result. We tried to convolve our signal with an empirical kernel of symptoms onset to
testing results delays distribution with mixed results. The data that we have access to is not from NYS.
Also, this delay probably changed during the epidemic, as testing availability increased. Access to a more
detailed database would allow us to estimate the onset of interventions with greater precision.
We show that when reliable data from the daily number of tests are available, the odds of positive is a
useful dependent variable. Other authors rely on deaths data [24], or hospitalization because they are more
robust than daily positive counts [33]. Since the delay between a person becoming infected to the result of
a test is lower than the average time to hospitalization or death, test results would detect hubs of infection,
earlier. For example, if there is a high-risk activity among young people since the youth are less likely to
be hospitalized or die from COVID-19[33], it would take longer to detected this activity using data from
hospitalizations than from tests. Another strategy to reduce the variance of the daily number of new cases is
to use the day of the week as a regressor [23] because there are obvious cycles associated to day of the week
in the data. However, when testing is ramping up, or there are shortages of supplies, this strategy would
fail. Then, the odds of a positive test is more robust than the number of positive tests. At the same time,
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Figure 3: Rt as a function of time. The black dashed vertical lines indicate different governmental interven-
tions: on March 16th close of bars, gyms and movie theaters, on March 18th school closure, on March 20th
50% of the workforce should remain at home, on March 22nd NY PAUSE (100% of the workforce should
remain at home), on April 3rd CDC recommended the use of masks, on April 12th NYS order front line
workers to wear a mask, on April 17th NYS orders the general public to wear a mask.
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it carries higher statistical power than data from hospitalizations or deaths.
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